Vapotherm Inc (NYSE:VAPO) Insider Buys $31,020.00 in Stock

Vapotherm Inc (NYSE:VAPO) insider John Landry bought 3,000 shares of the stock in a transaction on Thursday, September 5th. The stock was purchased at an average price of $10.34 per share, for a total transaction of $31,020.00. Following the completion of the purchase, the insider now directly owns 97,703 shares in the company, valued at $1,010,249.02. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

Shares of NYSE:VAPO opened at $8.70 on Thursday. The company’s fifty day moving average price is $13.80 and its 200-day moving average price is $17.74. The firm has a market capitalization of $166.24 million and a price-to-earnings ratio of -0.63. Vapotherm Inc has a one year low of $8.30 and a one year high of $24.63. The company has a debt-to-equity ratio of 1.42, a current ratio of 5.22 and a quick ratio of 4.34.

Vapotherm (NYSE:VAPO) last issued its quarterly earnings results on Monday, July 29th. The company reported ($0.76) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.81) by $0.05. The company had revenue of $11.99 million during the quarter, compared to the consensus estimate of $11.90 million. As a group, equities research analysts expect that Vapotherm Inc will post -3.07 EPS for the current year.

Separately, Zacks Investment Research upgraded shares of Vapotherm from a “hold” rating to a “buy” rating and set a $18.00 target price on the stock in a research note on Friday, August 2nd. Five equities research analysts have rated the stock with a buy rating, The company has an average rating of “Buy” and a consensus price target of $23.67.

Several large investors have recently modified their holdings of VAPO. Perceptive Advisors LLC increased its holdings in shares of Vapotherm by 12.7% in the 2nd quarter. Perceptive Advisors LLC now owns 1,404,470 shares of the company’s stock worth $32,302,000 after buying an additional 158,155 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of Vapotherm by 60.2% in the 2nd quarter. Vanguard Group Inc. now owns 376,660 shares of the company’s stock worth $8,663,000 after buying an additional 141,539 shares during the last quarter. Federated Investors Inc. PA increased its holdings in shares of Vapotherm by 32.8% in the 1st quarter. Federated Investors Inc. PA now owns 398,435 shares of the company’s stock worth $7,829,000 after buying an additional 98,435 shares during the last quarter. First Light Asset Management LLC increased its holdings in shares of Vapotherm by 24.6% in the 2nd quarter. First Light Asset Management LLC now owns 496,969 shares of the company’s stock worth $11,430,000 after buying an additional 97,977 shares during the last quarter. Finally, BlackRock Inc. increased its holdings in shares of Vapotherm by 24.7% in the 2nd quarter. BlackRock Inc. now owns 292,171 shares of the company’s stock worth $6,719,000 after buying an additional 57,950 shares during the last quarter. 50.85% of the stock is currently owned by hedge funds and other institutional investors.

Vapotherm Company Profile

Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.

Featured Article: What is the formula for the cash asset ratio?

Insider Buying and Selling by Quarter for Vapotherm (NYSE:VAPO)

Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.